Literature DB >> 2991432

Inhibition of herpes simplex virus type 1 penetration by cytochalasins B and D.

K S Rosenthal, R Perez, C Hodnichak.   

Abstract

Internalization of herpes simplex virus type 1 (HSV) KOS strain by HEp-2 cells was reversibly inhibited by pretreatment of cells with cytochalasins B and D. Internalization of virus following preincubation at 4 degrees C and temperature shift to 37 degrees C was normally preceded by a 5 to 8 min lag period and was complete within 20 to 30 min. A similar lag period followed HSV addition at 37 degrees C. Cytochalasin D was fivefold more active on HSV entry than cytochalasin B, with 50% inhibition at 2 microM and 10 microM respectively. Inhibition was completely reversible, such that all cell-bound infectious virus was recovered upon removal of cytochalasin. In conjunction with previous reports, the activity of cytochalasin on HSV entry suggests that a change in cytoskeletal structure following virus attachment triggers a microfilament activity important for internalization of HSV by HEp-2 cells.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2991432     DOI: 10.1099/0022-1317-66-7-1601

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  14 in total

1.  Entry of the two infectious forms of vaccinia virus at the plasma membane is signaling-dependent for the IMV but not the EEV.

Authors:  J K Locker; A Kuehn; S Schleich; G Rutter; H Hohenberg; R Wepf; G Griffiths
Journal:  Mol Biol Cell       Date:  2000-07       Impact factor: 4.138

2.  Requirements for different components of the host cell cytoskeleton distinguish ecotropic murine leukemia virus entry via endocytosis from entry via surface fusion.

Authors:  K Kizhatil; L M Albritton
Journal:  J Virol       Date:  1997-10       Impact factor: 5.103

3.  Characterization of fusion from without induced by herpes simplex virus.

Authors:  I Walev; K C Wollert; K Weise; D Falke
Journal:  Arch Virol       Date:  1991       Impact factor: 2.574

4.  Effect of cellular function inhibitors on the infection of Frp/3 cells by hepatitis A virus.

Authors:  F Superti; L Seganti; N Orsi; M Divizia; R Gabrieli; A Panà
Journal:  Med Microbiol Immunol       Date:  1989       Impact factor: 3.402

5.  Identification of a novel pathway essential for the immediate-early, interferon-independent antiviral response to enveloped virions.

Authors:  Ryan S Noyce; Susan E Collins; Karen L Mossman
Journal:  J Virol       Date:  2006-01       Impact factor: 5.103

6.  The Inhibition of DNA Viruses by the Amphibian Antimicrobial Peptide Temporin G: A Virological Study Addressing HSV-1 and JPCyV.

Authors:  Maria Elena Marcocci; Bianka Gabriela Jackowska; Carla Prezioso; Virginia Protto; Marta De Angelis; Francesco Saverio Di Leva; Bruno Casciaro; Alfonso Carotenuto; Maria Luisa Mangoni; Anna Teresa Palamara; Valeria Pietropaolo; Giovanna De Chiara; Lucia Nencioni
Journal:  Int J Mol Sci       Date:  2022-06-28       Impact factor: 6.208

7.  Inhibiting the Arp2/3 complex limits infection of both intracellular mature vaccinia virus and primate lentiviruses.

Authors:  Jun Komano; Kosuke Miyauchi; Zene Matsuda; Naoki Yamamoto
Journal:  Mol Biol Cell       Date:  2004-09-22       Impact factor: 4.138

Review 8.  Alphaherpesviruses and the cytoskeleton in neuronal infections.

Authors:  Sofia V Zaichick; Kevin P Bohannon; Gregory A Smith
Journal:  Viruses       Date:  2011-06-27       Impact factor: 5.048

9.  Daphne Genkwa sieb. Et zucc. Water-soluble extracts act on enterovirus 71 by inhibiting viral entry.

Authors:  Chia-Wen Chang; Yan-Lii Leu; Jim-Tong Horng
Journal:  Viruses       Date:  2012-04-11       Impact factor: 5.048

10.  Antiherpevirus activity of Artemisia arborescens essential oil and inhibition of lateral diffusion in Vero cells.

Authors:  Manuela Saddi; Adriana Sanna; Filippo Cottiglia; Lorenza Chisu; Laura Casu; Leonardo Bonsignore; Alessandro De Logu
Journal:  Ann Clin Microbiol Antimicrob       Date:  2007-09-26       Impact factor: 3.944

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.